{
  "_metadata": {
    "crawler_version": "1.0.0",
    "file_format_version": "1.0",
    "saved_at": "2026-01-12T09:56:41.413230"
  },
  "content": "This article **needs additional citations for verification**. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. *Find sources:* \"Biosensors International\" – news **·** newspapers **·** books **·** scholar **·** JSTOR *(March 2010)* *(Learn how and when to remove this message)*Medical device company based in Singapore **Biosensors International** **Group, Ltd.** is a [medical device](/wiki/Medical_device) company that specializes in developing, manufacturing and licensing technologies for use in [interventional cardiology](/wiki/Interventional_cardiology) procedures and [critical care](/wiki/Critical_care_medicine). The company was listed on the mainboard of the [Singapore Exchange](/wiki/Singapore_Exchange) (SGX) in May 2005. The global headquarters of the company is located in [Singapore](/wiki/Singapore) and holds the main manufacturing facilities and [research and development](/wiki/Research_and_development) centers. The European headquarters are in [Morges](/wiki/Morges), [Switzerland](/wiki/Switzerland). The Swiss office is also the legal manufacturer of BioMatrix, the company's current leading product. Biosensors International also licenses its proprietary [drug-eluting stent](/wiki/Drug-eluting_stent) technologies to other medical device companies and specialty stent providers, including [Terumo](/wiki/Terumo), Devax, Inc., and Xtent, Inc. Biosensors International Group has a joint-venture in [Hong Kong](/wiki/Hong_Kong) listed as Shandong Weigao to market and distribute [coronary stents](/wiki/Coronary_stent) in [China](/wiki/China). ## BioMatrix BioMatrix is a [drug-eluting stent](/wiki/Drug-eluting_stent) that utilizes proprietary technologies of Biosensors International: - A biodegradable Poly-Lactic Acid (PLA) polymer, which degrades into the naturally occurring [lactic acid](/wiki/Lactic_acid). - The [Biolimus A9](/wiki/Biolimus_A9) drug, a highly [lipophilic](/wiki/Lipophilic) derivative of [sirolimus](/wiki/Sirolimus). - The S-Stent stent platform. - An automated stent coating technology that directly deposits the coating onto the stent surface. [Biosensors](/wiki/Biosensor) obtained approval for this drug-eluting stent product in January 2008. - [Drug-eluting stent](/wiki/Drug-eluting_stent) - [Biolimus A9](/wiki/Biolimus_A9) ## Notes - Biosensors International Website This article about a [medical](/wiki/Medical), [pharmaceutical](/wiki/Pharmaceutical) or [biotechnological](/wiki/Biotechnological) corporation or company is a stub. You can help Wikipedia by expanding it. - v - t - e\n",
  "language": "en",
  "processed_at": "2026-01-12T09:56:41.412785",
  "title": "Biosensors International",
  "type": "article",
  "url": "https://en.wikipedia.org/wiki/Biosensors_International"
}